San Francisco, CA, United States of America

Matthew Sangyup Lee

USPTO Granted Patents = 5 

Average Co-Inventor Count = 17.8

ph-index = 2

Forward Citations = 10(Granted Patents)


Location History:

  • San Bruno, CA (US) (2013)
  • San Francisco, CA (US) (2012 - 2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew Sangyup Lee

Introduction

Matthew Sangyup Lee is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. With a total of five patents to his name, Lee's work focuses on innovative compounds that target critical biological pathways.

Latest Patents

Among his latest patents, Lee has developed inhibitors of the hedgehog pathway. These inventions are directed to a compound of Formula I or a single isomer thereof. The compounds can be presented as pharmaceutically acceptable salts, hydrates, solvates, or combinations thereof. Additionally, he has outlined methods for preparing these compounds and their applications in treating cancer.

Career Highlights

Matthew Sangyup Lee has worked with notable companies in the pharmaceutical industry, including Exelixis Patent Company LLC and Exelixis, Inc. His experience in these organizations has allowed him to refine his expertise in drug development and patenting innovative solutions.

Collaborations

Lee has collaborated with several professionals in his field, including Grace Mann and Jeff Z Chen. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Matthew Sangyup Lee's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing cancer treatment. His work continues to impact the industry positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…